Tetrabenazine Tablet
Product Images NDC 43598-395

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tetrabenazine (NDC 43598-395). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line graph comparing Chorea Score Change over Study Weeks between Tetrabenazine and placebo groups. The graph includes error bars representing standard error of the mean and highlights statistically significant differences (p<0.05). The Tetrabenazine group shows a greater decrease in Chorea Score Change over time with a noted washout period.*
FDA Label Image

Container1 (Container1)

Container1 (Container1)
Tetrabenazine Tablets 12.5 mg label from Dr. Reddys Laboratories Inc. The label includes the NDC 43598-394-67, indicates oral tablet form, and specifies 112 tablets per container. It features a pharmacist instruction to dispense with a medication guide, storage instructions, a QR code for medication guide, and barcode information.*
FDA Label Image

Container2 (Container2)

Container2 (Container2)
Tetrabenazine Tablets 25 mg oral tablets package label by Dr. Reddys Laboratories Inc. The label indicates prescription use, with a count of 112 tablets. It includes dosage information and pharmacist dispensing instructions along with a barcode and QR code for medication guide access.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A line graph comparing Tetrabenazine and Placebo showing cumulative percentage of patients versus change from baseline in chorea score. The graph illustrates greater improvement in chorea with Tetrabenazine treatment compared to Placebo over the study period marked by several score change points.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of tetrabenazine, showing its molecular framework with multiple ring systems, methoxy groups, and a ketone functionality.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.